Barrett's Oesophagus: A Review of Costs of the Illness

PharmacoEconomics

Volumn 19, Issue 10, 2001, Pages 1003-1011

  Arguedas, Miguel R ^a   Eloubeidi, Mohamad A ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; COST BENEFIT ANALYSIS; COST OF ILLNESS; DRUG COST; ECONOMICS; ESOPHAGOSCOPY; ESOPHAGUS TUMOR; HUMAN; REVIEW;

BARRETT ESOPHAGUS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DRUG COSTS; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; HUMAN;

EID: 0035226740     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200119100-00003     Document Type: Article

References (25)

1. Spechler SJ, Goyal RK. Barrett's esophasus. N Engl J Med 1986; 315: 362-71
2. Winters CJ, Spurling TJ, Chobanian SJ, et al. Barrett's esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987; 92: 118-24
3. Spechler SJ. Barrett's esophagus: what's new and what to do. Am J Gastroenterol 1989; 84: 220-3
4. Provenzale D, Schmitt C, Wong JB, et al. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 1999; 94: 2043-53
5. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-9
6. Blot WJ, Devesa SS, Fraumeni JF, et al. Continuing climb in rates of esophageal adenocarcinoma: an update [letter]. JAMA 1993; 270: 1320
7. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31
8. Sampliner RE, Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 1998; 93: 1028-32
9. Achkar E, Carey W The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. Am J Gastroenterol 1988; 83: 291-4
10. Provenzale D, Kemp JA, Arora S, et al. A guide for surveillance of patients with Barrett's esophagus Am J Gastroenterol 1994; 89: 670-80
11. Falk GW, Ours TM, Richter JE, et al. Practice patterns for surveillance of Barrett's esophagus in the United States. Gastrointest Endosc 2000; 52: 197-203
12. Gross CP, Canto MI, Hixson J, et al. Management of Barrett's esophagus: a national study of practice patterns and their cost implications: Am J Gastroenterol 1999; 94: 3440-7
13. Cruz-Corea M, Gross CP, Canto MI, et al. The impact of practice guidelines on management of Barrett's esophagus: a prospective cohort [abstract]. Am J Gastroenterol 2000; 95: 2627
14. Van Sandick J, Bartelsman JM, van Lanschot JJ, et al. Surveillance of Barrett's oesophagus: physicians' practices and review of current guidelines. Eur J Gastroenterol Hepatol 2000; 12: 111-7
15. Smith AM, Maxwell-Armstrong CA, Welch NT, et al. Surveillance for Barrett's oesophagus in the UK. Br J Surg 1999; 86: 276-80
16. Locke GR, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-56
17. Levin T, Schmittdiel J, Kunz K, et al. Costs of acid related disorders to a health maintenance organization. Am J Med 1997; 103: 520-8
18. Eloubeidi MA, Homan RK, Martz MD, et al. A cost analysis of outpatient care for patients with Barrett's esophagus in a managed care setting. Am J Gastroeaterol 1999; 94: 2033-6
19. Soni A, Sampliner RE, Sonnenberg A, et al. Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective? Am J Gastroenterol 2000; 95: 2086-93
20. Heudebert G, Centor R, Marks R, et al. Endoscopy in chronic heartburn to screen for Barrett's esophagus (BE): can we really afford it? [abstract]. Am J Gastroenterol 1998; 93: 1614
21. Wright TA, Gray MR, Morris AI, et al. Cost effectiveness of detecting Barrett's cancer. Gut 1996; 39: 574-9
22. Streitz JMJ, Ellis FHJ, Tilden RL, et al. Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer. Am J Gastroenterol 1998; 93: 911-5
23. Ofman JJ, Lewin K, Ramers C, et al. The economic impact of the diagnosis of dysplasia in Barrett's esophagus. Am J Gastroenterol 2000; 95: 2946-52
24. Osgard EM, Hirota WK, Maydonovitch CL, et al. A comparison of screening strategies to diagnose Barrett's esophagus [abstract]. Gastroenterology 2000; 116; AB: G 1200
25. Shaheen NJ, Crosby MA, Bozymski EM, et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000; 119: 333-8